If you’ve been watching Fair Isaac (FICO) lately, the company’s recent news might be piquing your interest. FICO just stepped into the global spotlight with two partnerships: one with Chelsea Football Club to promote financial literacy in the U.S., and another with the Nita Mukesh Ambani Cultural Centre (NMACC) for a high-profile cultural event in New York. These moves show FICO is reaching beyond its core analytics business, tapping into social and cultural campaigns to broaden its brand...
Motorola Solutions (NYSE:MSI) delivered plenty for investors to consider in its recent quarterly update. The company posted record-breaking revenue and earnings for the second quarter, with a standout 15% growth in its software and services segment. Alongside these results, management raised its projections for full-year sales, earnings per share, and operating cash flow. This move signals confidence in execution and future momentum, based on a steady stream of new products and...
Big news just landed for anyone following MARA Holdings (MARA). The company has announced the launch of its European headquarters in Paris, a move that signals a deliberate push into international markets. By establishing its base in the heart of Europe’s energy and technology scene, MARA Holdings is taking a clear step to strengthen its growth plans and compete for a bigger slice of the global market. For investors weighing their next move, this event marks a potentially pivotal chapter in...
Trinity Capital Inc. recently appointed Josh Mackey as Director of Tech Lending, bringing over a decade of experience from major financial institutions and a deep track record in supporting technology companies across the U.S.
This addition reflects a focused effort by Trinity to strengthen its tech lending capabilities and deepen its connections with emerging and established tech clients.
We will now explore how the appointment of Josh Mackey could reshape Trinity Capital’s investment...
In August 2025, Madrigal Pharmaceuticals announced that the European Commission granted conditional marketing authorization for Rezdiffra (resmetirom), making it the first and only approved therapy in the EU for adults with noncirrhotic MASH with moderate to advanced liver fibrosis.
This decision positions Rezdiffra to address a substantial unmet need in Europe, where approximately 370,000 patients are currently diagnosed and managed by liver specialists.
We'll examine how becoming the sole...
If you have been tracking ONEOK (OKE), you probably took notice this week when the company and its partners committed to constructing the Eiger Express Pipeline. This is not just another infrastructure announcement; it signals a major move in expanding natural gas transportation from the Permian Basin to key Gulf Coast markets. With firm long-term transportation agreements already in place, ONEOK appears to be focusing on high-demand energy corridors, a strategy that could influence its...
